Avalon BioVentures II, LP · CIK 2160318
Avalon BioVentures II, LP
Filings
1
Original notices
1
Amendments
0
Activity
Nov 12, 2026
through Nov 12, 2026
through Nov 12, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $200,000,000
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $0
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- AeroRx Therapeutics, Inc. · CIK 2090778
- Enlaza Therapeutics, Inc. · CIK 1852950
Form D filings (1)
-
0002160318-26-000001D · Nov 12, 2026 · Pooled Investment FundOffering: $200,000,000Sold: $0